Rakovina partners with Celvion: what it means for our ATR program

Preview text: Rakovina partners with Celvion: what it means for our ATR program A short take on how this…

Thursday, Oct 1, 2026 at 4:18 PM EasternMailchimp

Rakovina TherapeuticsRakovina partners with Celvion: what it means for our ATR program

Fit to screenFull size

Using this email in an article? Credit: Rakovina Therapeutics email via They Sent It, with a link to this page. Full-size image

Use this example

Subject: Rakovina partners with Celvion: what it means for our ATR program
Preview text: Rakovina partners with Celvion: what it means for our ATR program A short take on how this…
From: ir@rakovinatherapeutics.com
Brand: Rakovina Therapeutics
ESP: Mailchimp
Sent: Thu Oct 1, 2026, 4:18 PM ET
Size: 70 KB
Images: 7
Links: 12, 2 of them buttons
Subject length: 65 characters

Against Rakovina Therapeutics's usual

Sent in its busiest hour, 4 PM, which holds 31% of its emails. The subject is 65 characters; its average is 70.

Email headers

What the brand's servers put on this email. Our receiving servers, the address we subscribed with and unsubscribe links are left out.

Other sending headers (names only): X-Campaign, X-campaignid, X-Report-Abuse, X-MC-User, X-Accounttype

	Oct 22, 2026 4:17 PM	kt-5000AI update: what we’ve shown, and what’s next
	Oct 18, 2026 4:14 PM	Rakovina secures exclusivity on kt-5000 target profile · Resent
	Oct 15, 2026 10:30 AM	Rakovina secures exclusivity on kt-5000 target profile
	Oct 1, 2026 4:18 PM	Rakovina partners with Celvion: what it means for our ATR program (this email)
	Sep 17, 2026 4:45 AM	Rakovina Therapeutics Announces Appointment of New Scientific Advisory Board Member
	Sep 10, 2026 4:30 AM	Rakovina Therapeutics Announces Appointment of Professor Petra Hamerlik to its Board of Directors
	Aug 31, 2026 7:00 PM	Rakovina Therapeutics Announces Q2 2026 Financial Results and Provides Corporate Update